Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00309556
Status:
COMPLETED
Last Update Posted:
2011-12-30
First Post:
2006-03-31
Brief Title:
Randomized Neoadjuvant Study of Epirubicin and Docetaxel WithWithout Capecitabine in Early Breast Cancer
Sponsor:
Austrian Breast Colorectal Cancer Study Group
Organization:
Austrian Breast Colorectal Cancer Study Group